eEdition Subscribe Log in
Monday, May 20, 2024
36.0°F
This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday, Nov. 5, 2021 it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. (NIAID-RML via AP)

This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday, Nov. 5, 2021 it wi…

November 5, 2021

Stories this photo appears in:

Pfizer says COVID-19 pill cut hospital, death risk by 90%
November 5, 2021 11:35 a.m.

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible